Document
type: Class

Academic Article
type: Class

45356636
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer

Continuant
type: Class

Entity
type: Class

Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer
language: English
related by: 45356633
type: Article
type: Document
type: Continuant
related by: 45356636
type: Entity
most specific type: Academic Article
type: Information Content Entity
type: Academic Article
type: Generically Dependent Continuant
type: Thing

45356633
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer

Generically Dependent Continuant
type: Class

Article
type: Class

English
type: Language

Information Content Entity
type: Class

RDF description of Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer - http://irises.unimi.it/resource/item/464991
rights: termsOfUse
date: 2026-08-13T17:14:17
publisher: Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer
type: Document